Revolution Medicines Statistics

Total Valuation

RVMD has a market cap or net worth of $7.80 billion. The enterprise value is $5.89 billion.

Market Cap	7.80B
Enterprise Value	5.89B

Important Dates

The last earnings date was Wednesday, May 7, 2025, after market close.

Earnings Date	May 7, 2025
Ex-Dividend Date	n/a

Share Statistics

RVMD has 186.27 million shares outstanding. The number of shares has increased by 32.89% in one year.

Current Share Class	186.27M
Shares Outstanding	186.27M
Shares Change (YoY)	+32.89%
Shares Change (QoQ)	+8.28%
Owned by Insiders (%)	2.39%
Owned by Institutions (%)	98.59%
Float	168.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.62
P/TBV Ratio	3.92
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.46, with a Debt / Equity ratio of 0.06.

Current Ratio	13.46
Quick Ratio	13.26
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -36.68% and return on invested capital (ROIC) is -24.51%.

Return on Equity (ROE)	-36.68%
Return on Assets (ROA)	-23.09%
Return on Invested Capital (ROIC)	-24.51%
Return on Capital Employed (ROCE)	-35.77%
Revenue Per Employee	n/a
Profits Per Employee	-$1.31M
Employee Count	534
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-753,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.43% in the last 52 weeks. The beta is 1.11, so RVMD's price volatility has been higher than the market average.

Beta (5Y)	1.11
52-Week Price Change	+12.43%
50-Day Moving Average	37.66
200-Day Moving Average	43.95
Relative Strength Index (RSI)	60.49
Average Volume (20 Days)	2,029,072

Short Selling Information

The latest short interest is 16.55 million, so 8.88% of the outstanding shares have been sold short.

Short Interest	16.55M
Short Previous Month	16.43M
Short % of Shares Out	8.88%
Short % of Float	9.82%
Short Ratio (days to cover)	8.89

Income Statement

Revenue	n/a
Gross Profit	-679.95M
Operating Income	-789.43M
Pretax Income	-522.73M
Net Income	-697.51M
EBITDA	-782.75M
EBIT	-789.43M
Earnings Per Share (EPS)	-$4.02

Full Income Statement

Balance Sheet

The company has $2.10 billion in cash and $134.34 million in debt, giving a net cash position of $1.97 billion or $10.57 per share.

Cash & Cash Equivalents	2.10B
Total Debt	134.34M
Net Cash	1.97B
Net Cash Per Share	$10.57
Equity (Book Value)	2.08B
Book Value Per Share	11.16
Working Capital	1.98B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$591.31 million and capital expenditures -$10.41 million, giving a free cash flow of -$601.72 million.

Operating Cash Flow	-591.31M
Capital Expenditures	-10.41M
Free Cash Flow	-601.72M
FCF Per Share	-$3.23

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RVMD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-32.89%
Shareholder Yield	-32.89%
Earnings Yield	-8.87%
FCF Yield	-7.65%

Dividend Details

Analyst Forecast

The average price target for RVMD is $68.75, which is 64.16% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$68.75
Price Target Difference	64.16%
Analyst Consensus	Strong Buy
Analyst Count	12
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1